Intersect ENT (XENT) Tops Q2 EPS by 3c
Tweet
Share
E-mailIntersect ENT (NASDAQ: XENT) reported Q2 EPS of ($0.23), $0.03 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $14.74 million.
For earnings history and earnings-related data on Intersect ENT (XENT) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
